CFTR and cystic fibrosis: In a model of CF-MSCs, CFTR dysfunction associates with an enhanced sphingolipid metabolism leading to the release of EVs that export the excess of pro-inflammatory ceramides to the recipient cells, thus contributing to maintain the unresolved inflammatory status of CF [148].